News &amp; Updates

Remote ischaemic conditioning improves neurologic function in acute stroke

Treatment with remote ischaemic conditioning in adults with acute moderate ischaemic stroke appears to increase the chances of achieving excellent neurologic function at 90 days as compared with usual care, as shown in the results of an open-label, blinded-endpoint, randomized clinical trial.

Remote ischaemic conditioning improves neurologic function in acute stroke

22 Aug 2022

Pain relief in older adults minimal, incomplete with hydromorphone, acetaminophen drips

In the management of acute severe pain in older patients in the emergency department, hydromorphone provides only nonclinically significant greater effect than acetaminophen, with pain relief being minimal or incomplete regardless of the medication received, according to a study.

Pain relief in older adults minimal, incomplete with hydromorphone, acetaminophen drips

Oral antibiotics safe, feasible for select children with osteoarticular infection

In some patients with osteoarticular infections (OAIs), an exclusively oral administration of antibiotics is safe and feasible, suggests a study.

Oral antibiotics safe, feasible for select children with osteoarticular infection

Myocarditis not uncommon in cancer patients on immune checkpoint inhibitors

The incidence of myocarditis and myocardial damage is higher than expected in cancer patients receiving immune checkpoint inhibitor (ICI) treatment, reports a recent real-world study.

Myocarditis not uncommon in cancer patients on immune checkpoint inhibitors

Prior ultrasonography findings tied to cholangiocarcinoma diagnosis

A history of abnormalities found during ultrasonography appears to aggravate the diagnosis of cholangiocarcinoma, particularly among those with dilated bile ducts and liver mass, reports a recent Thailand study.

Prior ultrasonography findings tied to cholangiocarcinoma diagnosis

Retzius-sparing may be better than conventional RARP

Retzius-sparing robotic-assisted radical prostatectomy (rsRARP) leads to better continence recovery than conventional RARP (cRARP), a new study has found. Meanwhile, in anterior tumours, rsRARP is associated with higher positive surgical margins.

Retzius-sparing may be better than conventional RARP

Is bulevirtide a potential answer for chronic hep D?

20 Aug 2022 by

Bulevirtide at a dose of 2 mg or 10 mg daily induces biochemical and virological response in patients with chronic hepatitis D virus (HDV) infection, according to results of Study MYR301.

Is bulevirtide a potential answer for chronic hep D?

ASCL1 a potential therapeutic target for treating Cushing’s disease

A recent study attempting to understand the pathogenesis of Cushing’s disease (CD) suggests the potential of achaete-scute complex homolog 1 (ASCL1), a pioneer transcription factor, as a therapeutic target for the treatment of CD.

ASCL1 a potential therapeutic target for treating Cushing’s disease

20 Aug 2022

Albumin, lymphocyte-to-monocyte ratio tied to tacrolimus response in ulcerative colitis

Concentrations of albumin and the ratio between lymphocyte and monocyte counts can predict failure of tacrolimus treatment in patients with ulcerative colitis, reports a recent study.

Albumin, lymphocyte-to-monocyte ratio tied to tacrolimus response in ulcerative colitis